Clinical Trial Update: Pregabalin and Orofacial Neuropathic Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pregabalin for orofacial neuropathic pain was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Orofacial Pain

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: University of Toronto | Conditions: Neuropathic Pain, Orofacial Pain | Phase 2 | Status: TERMINATED